What does APOTEEK DE COSTER do?

APOTEEK DE COSTER is a logistics company in Zaventem. Public Limited, started on 11 January 1985, 1 establishment.

What is the address of APOTEEK DE COSTER?

The registered office of APOTEEK DE COSTER is located at Mechelsesteenweg 225, 1933 Zaventem.

Is APOTEEK DE COSTER still active?

Yes. According to the CBE (29 October 2026) APOTEEK DE COSTER is active, legal situation “Normale toestand”, started on 11 January 1985.

Is APOTEEK DE COSTER registered on Peppol?

Yes, APOTEEK DE COSTER is registered on the Peppol network with ID 0208:0426811480.

What is the enterprise number of APOTEEK DE COSTER?

The enterprise number of APOTEEK DE COSTER is BE0426811480.

When was APOTEEK DE COSTER founded?

APOTEEK DE COSTER was founded on 11 January 1985.

Who are the directors of APOTEEK DE COSTER?

According to the 2025 annual accounts, the directors of APOTEEK DE COSTER are: Maarten Mast, Mast & CO BV, Lies De Coster.

Is APOTEEK DE COSTER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 January 1985; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did APOTEEK DE COSTER make in 2025?

APOTEEK DE COSTER posted a profit after taxes of € 77,914 in financial year 2025.

What is the revenue of APOTEEK DE COSTER?

As a small company, APOTEEK DE COSTER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 280,332.

How much does an employee at APOTEEK DE COSTER earn?

The average wage cost per full-time employee at APOTEEK DE COSTER was € 81,000 in 2025: staff costs of € 145,826 for 1.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTEEK DE COSTER have?

According to the 2025 annual accounts, APOTEEK DE COSTER has 1.8 full-time equivalents (FTE).

APOTEEK DE COSTER (Public Limited) - Zaventem

Dossier APOTEEK DE COSTER, printed on 29 October 2026 from databakkes.be/en/0426811480/apoteek-de-coster. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTEEK DE COSTER from Zaventem, company number BE0426811480, closed financial year 2025 with a result of € 77,914 after tax. For that financial year APOTEEK DE COSTER recorded a gross margin of € 280,332 and equity of € 215,017. Compared with financial year 2024, the result moved from € 134,339 to € 77,914. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 215,017

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 77,914

▼ 42% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 167,432

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

64 % of the profit went to the shareholders, mostly to MAST & CO (99 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.8

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 145,826

▲ 7% vs 2024

€ 81,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,405

▼ 40% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 115,109

▼ 10% vs 2024

€ 12,316 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 134,472

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 21,696

▼ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 333,189 Gross margin 2022: € 333,189 First fiscal year in the series	€ 335,371 Gross margin 2023: € 335,371 ▲ 1% vs 2022 (€ 333,189) Favourable step	€ 339,245 Gross margin 2024: € 339,245 ▲ 1% vs 2023 (€ 335,371) Favourable step	€ 280,332 Gross margin 2025: € 280,332 ▼ 17% vs 2024 (€ 339,245) Unfavourable step	▼ 17%
Profit after taxes	€ 124,460 Profit after taxes 2022: € 124,460 First fiscal year in the series	€ 111,140 Profit after taxes 2023: € 111,140 ▼ 11% vs 2022 (€ 124,460) Unfavourable step	€ 134,339 Profit after taxes 2024: € 134,339 ▲ 21% vs 2023 (€ 111,140) Favourable step	€ 77,914 Profit after taxes 2025: € 77,914 ▼ 42% vs 2024 (€ 134,339) Unfavourable step	▼ 42%
Equity	€ 91,624 Equity 2022: € 91,624 First fiscal year in the series	€ 127,764 Equity 2023: € 127,764 ▲ 39% vs 2022 (€ 91,624) Favourable step	€ 187,103 Equity 2024: € 187,103 ▲ 46% vs 2023 (€ 127,764) Favourable step	€ 215,017 Equity 2025: € 215,017 ▲ 15% vs 2024 (€ 187,103) Favourable step	▲ 15%
Total debts	€ 532,610 Total debts 2022: € 532,610 First fiscal year in the series	€ 444,514 Total debts 2023: € 444,514 ▼ 17% vs 2022 (€ 532,610) Favourable step	€ 445,782 Total debts 2024: € 445,782 Unchanged (€ 444,514) Unfavourable step	€ 363,506 Total debts 2025: € 363,506 ▼ 18% vs 2024 (€ 445,782) Favourable step	▼ 18%
Cash	€ 171,009 Cash 2022: € 171,009 First fiscal year in the series	€ 158,757 Cash 2023: € 158,757 ▼ 7% vs 2022 (€ 171,009) Unfavourable step	€ 257,600 Cash 2024: € 257,600 ▲ 62% vs 2023 (€ 158,757) Favourable step	€ 167,432 Cash 2025: € 167,432 ▼ 35% vs 2024 (€ 257,600) Unfavourable step	▼ 35%
Land & buildings	€ 111,322 Land & buildings 2022: € 111,322 First fiscal year in the series	€ 99,720 Land & buildings 2023: € 99,720 ▼ 10% vs 2022 (€ 111,322) Unchanged	€ 88,640 Land & buildings 2024: € 88,640 ▼ 11% vs 2023 (€ 99,720) Unchanged	€ 77,560 Land & buildings 2025: € 77,560 ▼ 12% vs 2024 (€ 88,640) Unchanged	▼ 12%
Retained profit	€ 29,624 Retained profit 2022: € 29,624 First fiscal year in the series	€ 65,764 Retained profit 2023: € 65,764 ▲ 122% vs 2022 (€ 29,624) Favourable step	€ 125,103 Retained profit 2024: € 125,103 ▲ 90% vs 2023 (€ 65,764) Favourable step	€ 153,017 Retained profit 2025: € 153,017 ▲ 22% vs 2024 (€ 125,103) Favourable step	▲ 22%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 75,000 Dividend 2023: € 75,000 ▼ 25% vs 2022 (€ 100,000) Unchanged	€ 75,000 Dividend 2024: € 75,000 Unchanged (€ 75,000) Unchanged	€ 50,000 Dividend 2025: € 50,000 ▼ 33% vs 2024 (€ 75,000) Unchanged	▼ 33%
Bank debt	€ 221,457 Bank debt 2022: € 221,457 First fiscal year in the series	€ 166,034 Bank debt 2023: € 166,034 ▼ 25% vs 2022 (€ 221,457) Favourable step	€ 127,765 Bank debt 2024: € 127,765 ▼ 23% vs 2023 (€ 166,034) Favourable step	€ 115,109 Bank debt 2025: € 115,109 ▼ 10% vs 2024 (€ 127,765) Favourable step	▼ 10%
Balance sheet total	€ 624,234 Balance sheet total 2022: € 624,234 First fiscal year in the series	€ 572,278 Balance sheet total 2023: € 572,278 ▼ 8% vs 2022 (€ 624,234) Unchanged	€ 632,884 Balance sheet total 2024: € 632,884 ▲ 11% vs 2023 (€ 572,278) Unchanged	€ 578,522 Balance sheet total 2025: € 578,522 ▼ 9% vs 2024 (€ 632,884) Unchanged	▼ 9%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 ▲ 0.1 vs 2022 (1.6) Unchanged	1.8 Employees (FTE) 2024: 1.8 ▲ 0.1 vs 2023 (1.7) Unchanged	1.8 Employees (FTE) 2025: 1.8 Unchanged (1.8) Unchanged

Key figures of APOTEEK DE COSTER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTEEK DE COSTER?

What happened at APOTEEK DE COSTER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 77,914 (▼ 42% vs 2024). filed late Source: NBB ↗
2014 Maarten Mast became a director. NBB
2014 Mast & CO BV became a director. NBB
2014 Lies De Coster became a director. NBB
Jan 11, 1985 New establishment in Zaventem. KBO
Jan 11, 1985 Start of the company according to the CBE. KBO

In short

From € 124,460 profit in 2022 to € 77,914 profit in 2025.

Paid € 50,946 in corporate taxes since 2022.

Best year ever: 2024, with € 134,339 profit.

On average € 155,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MAST & CO 99%

The stake of MAST & CO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTEEK DE COSTER

Behind APOTEEK DE COSTER are Maarten Mast, Mast & CO BV and Lies De Coster. The shares are held by MAST & CO (99%).

Directors

According to the 2025 annual accounts

Maarten Mast

Director

Also active at: APOTHEEK MAST, Autonoom Gemeentebedrijf Merchtem

since 2014

Mast & CO BV

Director · represented by De Coster Lies

since 2014

Lies De Coster

Director

Also active at: MAST & CO

since 2014

Shareholders

MAST & CO

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Mechelsesteenweg 225

1933 Zaventem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ALPLAN

€ 26,643 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.811.480

VAT number

BE 0426.811.480

Registered office

Mechelsesteenweg 225, 1933 Zaventem

Names & denominations

APOTEEK DE COSTER

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

11 January 1985

Peppol

Active · Active since 25 Nov 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTEEK DE COSTER

Financials

What happened to APOTEEK DE COSTER?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions